![Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37efcaf1312c5ca35047d184682c7857630cce38/4-Table1-1.png)
Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar
![Nutrients | Free Full-Text | Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants Nutrients | Free Full-Text | Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants](https://www.mdpi.com/nutrients/nutrients-12-02218/article_deploy/html/images/nutrients-12-02218-g001-550.jpg)
Nutrients | Free Full-Text | Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants
![In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413120303168-fx1.jpg)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect
![Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study - Farnier - 2009 - International Journal Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study - Farnier - 2009 - International Journal](https://onlinelibrary.wiley.com/cms/asset/9956d93b-0850-441c-998c-f24abd326214/ijcp_2022_f1.gif)
Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study - Farnier - 2009 - International Journal
![IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?](https://www.mdpi.com/ijms/ijms-23-09326/article_deploy/html/images/ijms-23-09326-g003.png)
IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-02.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.001.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT](https://www.arzneimitteltherapie.de/_Resources/Persistent/8/b/1/9/8b19b93cb7a7a159801aeef75ff97af9398b1c39/lipp-rosuvastatin_01_converted_eps.png)
Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT
![Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease](https://www.ti.ubc.ca/wordpress/wp-content//uploads/2013/01/87-fig1.jpg)